TransMedics (TMDX) - Bathi resik saben saham (EPS TTM)

TransMedics Group (TMDX) ensures stable demand through its unique OCS systems for organ preservation. The annual net income per share trend confirms the resilience of a business that remains independent of economic cycles. Organic growth is further supplemented by the establishment of its own aviation logistics. The current value of 3.63 determines this parameter level, demonstrating the company's ability to monetize its technological advantages.

Net income per share (TTM) measures the actual return on each share of capital over a rolling year, allowing for an assessment of business efficiency without the influence of one-off factors. By analyzing the history of rolling earnings per share, an investor determines the fairness of the market valuation of TransMedics Group (TMDX), where the rapid adoption of OCS systems must transform into a sustainable positive trend for this indicator.